Literature DB >> 8518862

Improved results using a modification of the Young-Dees-Leadbetter bladder neck repair.

J A Jones1, M E Mitchell, R C Rink.   

Abstract

Forty-seven patients with primary total incontinence underwent bladder neck reconstruction (BNR) between 1978 and 1988. This included 31 patients with exstrophy/epispadias, 14 with myelomeningocele and 2 with caecoureteroceles. The patients were divided into 5 groups based on the type of BNR: Group 1--standard Young-Dees-Leadbetter (YDL) BNR; Group 2--YDL+Silastic sheath; Group 3--modified YDL; Group 4--Kropp BNR; Group 5--other BNRs. Group 1 included 18 patients with a 45% primary continence failure rate, a 44% reoperation rate and only a fair ability to void spontaneously after BNR. There were 11 patients in Group 3 with a 9% primary continence failure rate, a 27% reoperation rate and excellent post-operative emptying. None of the 3 patients in Group 4 was incontinent post-operatively, but they all required reoperation and had poor post-operative emptying. We feel that the modified YDL BNR provides better overall voiding and continence with less morbidity than the other bladder neck/urethral reconstructive procedures.

Entities:  

Mesh:

Year:  1993        PMID: 8518862     DOI: 10.1111/j.1464-410x.1993.tb16024.x

Source DB:  PubMed          Journal:  Br J Urol        ISSN: 0007-1331


  4 in total

1.  The management of urinary incontinence.

Authors:  P S Malone
Journal:  Arch Dis Child       Date:  1997-08       Impact factor: 3.791

Review 2.  Female bladder exstrophy.

Authors:  S J Crankson; S Ahmed
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  1997

Review 3.  Management options for sphincteric deficiency in adults with neurogenic bladder.

Authors:  Jeremy B Myers; Erik N Mayer; Sara Lenherr
Journal:  Transl Androl Urol       Date:  2016-02

4.  A fresh "slant" on modified Mitchell bladder neck reconstruction: A contemporary single-institution experience.

Authors:  Diana K Bowen; Earl Y Cheng; Josephine Hirsch; Jason Huang; Theresa Meyer; Ilina Rosoklija; David I Chu; Elizabeth B Yerkes
Journal:  Front Pediatr       Date:  2022-09-02       Impact factor: 3.569

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.